Review: could Glimepiride cause Bladder Cancer?


Bladder cancer is found among people who take Glimepiride, especially for people who are male, 60+ old , have been taking the drug for 1 - 6 months, also take medication Actos, and have Type 2 diabetes mellitus . We study 12,102 people who have side effects while taking Glimepiride from FDA and social media. Among them, 34 have Bladder cancer. Find out below who they are, when they have Bladder cancer and more.

You are not alone

Join a support group for people who take Glimepiride and have Bladder cancer >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Glimepiride has active ingredients of glimepiride. It is often used in diabetes. (latest outcomes from Glimepiride 12,741 users)

Bladder Cancer

Bladder cancer has been reported by people with thrombocytopenia, urinary tract infection, haematuria, urination - painful, fatigue (latest reports from 7,238 Bladder cancer patients).

On Aug, 26, 2016

12,102 people reported to have side effects when taking Glimepiride.
Among them, 34 people (0.28%) have Bladder Cancer

Number of reports submitted per year:

Could Glimepiride cause Bladder cancer?

Time on Glimepiride when people have Bladder Cancer *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Bladder Cancer when taking Glimepiride *:

  • female: 32.35 %
  • male: 67.65 %

Age of people who have Bladder Cancer when taking Glimepiride *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 3.57 %
  • 40-49: 0.0 %
  • 50-59: 7.14 %
  • 60+: 89.29 %

Severity if Bladder Cancer when taking Glimepiride **:

  • least: 0.0 %
  • moderate: 0.0 %
  • severe: 0.0 %
  • most severe: 100 %

Top conditions involved for these people *:

  • Type 2 Diabetes Mellitus (12 people)
  • Diabetes Mellitus (8 people)
  • Hypertension (6 people)
  • Hypercholesterolaemia (3 people)
  • Coronary Artery Disease (2 people)

Top co-used drugs for these people *:

  • Actos (11 people)
  • Metformin Hcl (10 people)
  • Aspirin (9 people)
  • Atrovent (7 people)
  • Zocor (6 people)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Bladder cancer when taking Glimepiride?

Browse all side effects of Glimepiride

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Bladder cancer

Bladder cancer

Could your condition cause Bladder cancer

Bladder cancer

You may be interested in these reviews

More reviews for: Glimepiride, Bladder cancer

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.